ATE513559T1 - Zusammensetzung mit phosphatidylserin und einem antigen oder allergen und ihre verwendung - Google Patents
Zusammensetzung mit phosphatidylserin und einem antigen oder allergen und ihre verwendungInfo
- Publication number
- ATE513559T1 ATE513559T1 AT05813465T AT05813465T ATE513559T1 AT E513559 T1 ATE513559 T1 AT E513559T1 AT 05813465 T AT05813465 T AT 05813465T AT 05813465 T AT05813465 T AT 05813465T AT E513559 T1 ATE513559 T1 AT E513559T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- allergen
- composition containing
- immune
- containing phosphatidylserine
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 title 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 title 1
- 102100023962 Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 Human genes 0.000 abstract 2
- 238000009169 immunotherapy Methods 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 108010077613 phosphatidylserine receptor Proteins 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 230000003828 downregulation Effects 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000008102 immune modulation Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0426481.8A GB0426481D0 (en) | 2004-12-02 | 2004-12-02 | Composition |
| PCT/GB2005/004656 WO2006059142A1 (en) | 2004-12-02 | 2005-12-02 | Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE513559T1 true ATE513559T1 (de) | 2011-07-15 |
Family
ID=34043954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05813465T ATE513559T1 (de) | 2004-12-02 | 2005-12-02 | Zusammensetzung mit phosphatidylserin und einem antigen oder allergen und ihre verwendung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8765721B2 (de) |
| EP (1) | EP1827488B1 (de) |
| JP (1) | JP2008521871A (de) |
| AT (1) | ATE513559T1 (de) |
| AU (1) | AU2005311034A1 (de) |
| CA (1) | CA2587247A1 (de) |
| GB (1) | GB0426481D0 (de) |
| MX (1) | MX2007006518A (de) |
| NZ (1) | NZ554974A (de) |
| WO (1) | WO2006059142A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2569907T3 (es) * | 2008-06-27 | 2016-05-13 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| EP2918262B1 (de) * | 2014-03-10 | 2023-08-09 | PLS-Design GmbH | Induktion einer antigenspezifischen Toleranz durch periphere Phagozytose |
| EP3251662A1 (de) * | 2016-06-07 | 2017-12-06 | Tolerogenics S.à.r.l. | In eine matrix eingebettete toleranzförderungsadjuvantien zur subkutanen immuntherapie |
| US11123324B2 (en) | 2016-08-18 | 2021-09-21 | Noster Inc. | Immunomodulator |
| US11197910B1 (en) * | 2020-08-19 | 2021-12-14 | Vitruviae LLC | Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07107536B2 (ja) | 1987-06-11 | 1995-11-15 | 鐘淵化学工業株式会社 | リポソ−ムを用いた高感度免疫学的測定法 |
| NZ230424A (en) | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
| RU94040856A (ru) | 1992-03-03 | 1996-08-20 | Дайити Фармасьютикал Ко. | Вакцина для перорального введения |
| JPH05339169A (ja) * | 1992-03-03 | 1993-12-21 | Dai Ichi Seiyaku Co Ltd | 経口ワクチン |
| JPH0912480A (ja) | 1995-06-30 | 1997-01-14 | Nippon Oil & Fats Co Ltd | 抗原結合リポソーム型ワクチン |
| US6187335B1 (en) * | 1997-12-31 | 2001-02-13 | Orasomal Technologies, Inc. | Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| US6300308B1 (en) | 1997-12-31 | 2001-10-09 | Board Of Regents, The University Of Texas System | Methods and compositions for inducing autoimmunity in the treatment of cancers |
| CA2319928A1 (en) | 2000-09-18 | 2002-03-18 | Vasogen Ireland Limited | Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
-
2004
- 2004-12-02 GB GBGB0426481.8A patent/GB0426481D0/en not_active Ceased
-
2005
- 2005-12-02 EP EP05813465A patent/EP1827488B1/de not_active Expired - Lifetime
- 2005-12-02 US US11/720,284 patent/US8765721B2/en active Active
- 2005-12-02 JP JP2007543927A patent/JP2008521871A/ja active Pending
- 2005-12-02 AU AU2005311034A patent/AU2005311034A1/en not_active Abandoned
- 2005-12-02 CA CA002587247A patent/CA2587247A1/en not_active Abandoned
- 2005-12-02 MX MX2007006518A patent/MX2007006518A/es not_active Application Discontinuation
- 2005-12-02 AT AT05813465T patent/ATE513559T1/de not_active IP Right Cessation
- 2005-12-02 WO PCT/GB2005/004656 patent/WO2006059142A1/en not_active Ceased
- 2005-12-02 NZ NZ554974A patent/NZ554974A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ554974A (en) | 2010-04-30 |
| EP1827488B1 (de) | 2011-06-22 |
| US8765721B2 (en) | 2014-07-01 |
| JP2008521871A (ja) | 2008-06-26 |
| GB0426481D0 (en) | 2005-01-05 |
| CA2587247A1 (en) | 2006-06-08 |
| WO2006059142A1 (en) | 2006-06-08 |
| MX2007006518A (es) | 2007-11-15 |
| US20080107684A1 (en) | 2008-05-08 |
| EP1827488A1 (de) | 2007-09-05 |
| AU2005311034A1 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1778831A4 (de) | Genetisch modifizierte wirtszellen und ihre verwendung zur herstellung von isoprenoid-zusammensetzungen | |
| ATE460944T1 (de) | Verfahren und zusammensetzungen zur herstellung und steuerung des effektorprofils von t-zellen durch gleichzeitiges beladen und aktivieren ausgewählter untergruppen von antigen- präsentierenden zellen | |
| DE502004001052D1 (de) | Verwendung von polysilazan zur herstellung von hydrophob- und oleophobmodifizierten oberflächen | |
| IL186245A0 (en) | Charged lipoprotein complexes and their used | |
| NL1023801A1 (nl) | Werkwijze voor het instellen van de Wobbe-index van een brandstof en samenstellingen daarvan. | |
| IL180588A0 (en) | Humanized anti-cmet antagonists | |
| PL2135881T3 (pl) | Przeciwciała wiążące się z antygenem TAT10772 związanym z nowotworem, do diagnozowania i leczenia nowotworu | |
| DE602004025463D1 (de) | Verwendung von ciclesonide zur erhaltung des feinen teilchengrössenanteils von formoterol | |
| BRPI0406889A (pt) | Aditivo adesivo, composição adesiva, e, compósito | |
| ZA200701137B (en) | Triazolophthalazines | |
| ATE529401T1 (de) | Aminocyclohexylether-verbindungen und deren verwendung | |
| DE60332096D1 (de) | Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität | |
| EA200702074A1 (ru) | Новые соединения | |
| ATE519727T1 (de) | 4-chlor-4-alkoxy-1,1,1-trifluor-2-butanone, deren herstellung und deren verwendung bei der herstellung von 4-alkoxy-1,1,1-trifluor-3-buten-2-onen | |
| ATE513559T1 (de) | Zusammensetzung mit phosphatidylserin und einem antigen oder allergen und ihre verwendung | |
| IL217561A0 (en) | Use of cytokininis to increase the ratio of wild type to mutant protein in cells | |
| BRPI0510938A (pt) | vitamina k1 como energizador em formulações cosméticas | |
| FR2855057B1 (fr) | Composition cosmetique ou dermopharmaceutique amincissante | |
| SE0203057L (sv) | Uppfinning som visar platsen i asfaltverkets blandare där finfraktionenes material skall tillsättas | |
| DE602005007492D1 (de) | Modifizierte polymere und ihre verwendung bei der herstellung von lithographischen druckplattenvorläufern | |
| Fowler et al. | Bortezomib, Bendamustine, and Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma: Encouraging Activity in the Phase 2 VERTICAL Study. | |
| WO2005040339A3 (en) | Aptamers to human epidermal growth factor receptor-3 | |
| ATE371662T1 (de) | Siliziumverbindungen und deren verwendung | |
| EP4326723A4 (de) | Pyrimido[5,4,d pyrimidin-verbindungen, diese enthaltende zusammensetzungen und ihre verwendung | |
| AU2003298604A1 (en) | Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |